🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Vrushaly Shinglot

Houston Methodist

ORCID: 0000-0003-3414-5526

Also affiliated with The University of Texas at Dallas

Physics and AstronomyBiochemistry, Genetics and Molecular BiologyMedicineEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer”.

Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer

medRxiv(2024)10.1101/2024.03.14.24304306

N/A

0.165DataRank · unranked

2 citations

Vrushaly Shinglot, Javier Ruiz-Ramírez, Joseph Cave, Joseph D. Butner, Carmine Schiavone +9 more

Mechanistic modeling of anti-microRNA-155 therapy combinations in lung cancer

PubMed(2023)10.1109/embc40787.2023.10341114

N/A

0DataRank · unranked

9 citations

Vrushaly Shinglot, Joseph D. Butner, Vittorio Cristini, Bülent Özpolat, George A. Calin +3 more

Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer

Molecular Cancer(2024)10.1186/s12943-024-02060-5

N/A

0DataRank · unranked

24 citations

Vrushaly Shinglot, Javier Ruiz-Ramírez, Joseph Cave, Joseph D. Butner, Carmine Schiavone +9 more